And yes, another article today about the Youtube channel Bloomberg Television, you are starting to be used to it you who follow assiduously Croblanc for so many years already! The interest for this channel keeps growing over the years and we are very happy to share it with you once again. Sometimes we hesitate to write an article because we don't know if you will like it, but today we know that this video will interest you.
The Youtube channel Bloomberg Television has published today a new video called Copy-cats of weight-loss drugs Ozempic and Wegovy are hurting Novo Nordisk. You want to discover this video and watch it in streaming, you are lucky we put it aside for you!
Many people have been talking about this new video for several hours on social networks and it has also generated many comments on the forums found on the web. Moreover, the Youtube channel Bloomberg Television is not new to publishing a video that is causing a stir. We know that you are often very interested in this type of content.
What is convenient with the Internet is that when you have a problem with a content, you can easily contact its author to let him know. First solution to contact the author of this video is on Youtube: Try to find his email address in "About". If you don't get an answer, you can try again to contact him but on another platform. Twitter seems to be a pretty easy way to contact a Youtuber about one of his contents.
Well it's almost time to conclude this paper, you can watch the video Copy-cats of weight-loss drugs Ozempic and Wegovy are hurting Novo Nordisk again if you want, it should be available for some time. In our platform, you can find other videos of Bloomberg Television, take a look at it occasionally, it's practical and it can allow you to find contents that you had never seen before on the web!
Looking forward to discovering new contents with you, see you next time on Croblanc!
For your information, you can find below the description of the video Copy-cats of weight-loss drugs Ozempic and Wegovy are hurting Novo Nordisk published by the Youtube channel Bloomberg Television:
Novo Nordisk’s weight loss drugs Ozempic and Wegovy transformed the firm into a global pharmaceutical giant.
But four years after Wegovy’s US launch, the Danish drugmaker’s market value has plummeted.
@sanne_wass explains why http://bloom.bg/4lWJtL8
Novo’s copycat problem wasn’t supposed to last this long. It began when the company was unable to meet customer demand for its weight-loss drugs in the US, clearing the way for compounding pharmacies to step in. These pharmacies are allowed to make and sell cheaper copies of a medicine when brand-name drugs are in short supply, and their products don’t go have to go through the same rigorous approval process.